Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOPAMINE vs DOSTARLIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOPAMINE vs DOSTARLIMAB: Safety Overview

Metric DOPAMINE DOSTARLIMAB
Total FAERS Reports 942 893
Deaths Reported 325 130
Death Rate 34.5% 14.6%
Hospitalizations 496 441
Average Patient Age 44.7 yrs 65.8 yrs
% Female Patients 48.6% 91.6%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer HF Acquisition Co LLC, DBA HealthFirst GlaxoSmithKline LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued N/A